TFEB and breast carcinoma: However, in both in vitro and in vivo models of breast cancer, Urolithin A has been shown to preserve the tumoricidal function of TAMs by inducing transcription factor EB (TFEB)-mediated mitophagy, partially via mTOR inhibition; this process concurrently decreases the M2-type TAM population within TIME (47).